These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 6296183

  • 21. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR, Boccagno JA, Steinbacher TE, Horovitz ZP, Murthy VS.
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [Abstract] [Full Text] [Related]

  • 22. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
    Mizuno K, Shigetomi S, Haruyama K, Matsui J, Gotho M, Fukuchi S.
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
    [No Abstract] [Full Text] [Related]

  • 23. Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat.
    Ploth DW, Rudulph J, LaGrange R, Navar LG.
    J Clin Invest; 1979 Nov; 64(5):1325-35. PubMed ID: 227932
    [Abstract] [Full Text] [Related]

  • 24. [The treatment of severe arterial hypertension in patients with chronic kidney failure with captopril and beta-adrenoblockaders].
    Ermolenko VM, Lifshits NL, Zisel'man SB, Tatsievskiĭ VA.
    Urol Nefrol (Mosk); 1991 Nov; (3):41-8. PubMed ID: 1871923
    [Abstract] [Full Text] [Related]

  • 25. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P, Genest J, Kuchel O, Boucher R, Gutkowska Y, McKinstry D.
    Can Med Assoc J; 1979 Aug 04; 121(3):309-16. PubMed ID: 223756
    [Abstract] [Full Text] [Related]

  • 26. The effect of in vitro captopril and angiotensin II on plasma renin activity.
    Roulston JE, Wathen CG.
    Clin Chim Acta; 1984 Mar 27; 138(1):99-103. PubMed ID: 6370512
    [Abstract] [Full Text] [Related]

  • 27. Suppression of captopril-induced increase in plasma renin activity by des-Asp1-,Ileu8-angiotensin II in man.
    Kono T, Ikeda F, Oseko F, Imura H, Endo J.
    J Clin Endocrinol Metab; 1981 Feb 27; 52(2):354-8. PubMed ID: 7007404
    [Abstract] [Full Text] [Related]

  • 28. Combined converting enzyme inhibition and angiotensin receptor blockade reduce proteinuria greater than converting enzyme inhibition alone: insights into mechanism.
    Panos J, Michelis MF, DeVita MV, Lavie RH, Wilkes BM.
    Clin Nephrol; 2003 Jul 27; 60(1):13-21. PubMed ID: 12872853
    [Abstract] [Full Text] [Related]

  • 29. Acute effects of captopril on serum angiotensin-converting enzyme activity, the renin-aldosterone system and blood pressure in patients with sarcoidosis.
    Mizuno K, Gotoh M, Matsui J, Nagasawa S, Fukuchi S.
    Tohoku J Exp Med; 1983 May 27; 140(1):107-8. PubMed ID: 6306866
    [Abstract] [Full Text] [Related]

  • 30. Responses of active and inactive plasma renin and changes in urinary kallikrein and plasma prekallikrein to various conditions in normal subjects.
    Nakamaru M, Ogihara T, Higaki J, Hata T, Ohde H, Naka T, Masuo K, Gotoh S, Kumahara Y, Murakami K.
    J Clin Endocrinol Metab; 1982 Apr 27; 54(4):682-8. PubMed ID: 7037811
    [Abstract] [Full Text] [Related]

  • 31. Effects of angiotensin I converting enzyme inhibition and calcium channel blockade on plasma levels of active and inactive renin in conscious rabbits.
    Eisen V, Munday MR, Slater JD.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2331-5. PubMed ID: 2440439
    [Abstract] [Full Text] [Related]

  • 32. Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
    Kee CS, Choi JW, Chang DK, Ahn YH, Kim HJ.
    J Korean Med Sci; 1993 Dec 15; 8(6):464-70. PubMed ID: 8179835
    [Abstract] [Full Text] [Related]

  • 33. Hemodynamic response to converting enzyme inhibition at rest and exercise in humans.
    Fagard R, Lijnen P, Vanhees L, Amery A.
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Sep 15; 53(3):576-81. PubMed ID: 6290435
    [Abstract] [Full Text] [Related]

  • 34. Active and inactive renin after captopril (SQ 14225) administration in hypertensive patients.
    Goto T, Abe K, Otsuka Y, Seino M, Ito T, Imai Y, Haruyama T, Sato M, Hiwatari M, Sato K, Omata K, Kasai Y, Tajima J, Yoshinaga K.
    Tohoku J Exp Med; 1983 Jan 15; 139(1):103-11. PubMed ID: 6340244
    [Abstract] [Full Text] [Related]

  • 35. Time course of the changes in active and cryoactivatable renin in response to acute stimuli before and after diuretic therapy in man.
    Morganti A, Sala C, Turolo L, Zanchetti A.
    Clin Exp Hypertens A; 1982 Jan 15; 4(11-12):2403-13. PubMed ID: 6756704
    [Abstract] [Full Text] [Related]

  • 36. Trypsin activable renin in rat plasma. Effects of acute and chronic perturbation of the renin system.
    Barrett JD, Eggena P, Sambhi MP.
    Clin Exp Hypertens A; 1982 Jan 15; 4(11-12):2233-46. PubMed ID: 6756693
    [Abstract] [Full Text] [Related]

  • 37. Similarity between active and trypsin-activated inactive renin in dog plasma by means of renin inhibition: the dog as an animal model for studies of inactive renin.
    Tonolo G, Tree M, Pazzola A, Leckie BJ.
    J Hypertens; 1988 Dec 15; 6(12):975-80. PubMed ID: 3065412
    [Abstract] [Full Text] [Related]

  • 38. Active and inactive renin in low renin states: studies in human plasma.
    Antonipillai I, Tan SY, Suzuki S, Franco-Saenz R, Mulrow PJ.
    J Clin Endocrinol Metab; 1981 Oct 15; 53(4):694-7. PubMed ID: 7026585
    [Abstract] [Full Text] [Related]

  • 39. The changes in active and inactive renin induced by various maneuvers in hypertensive patients.
    Goto T, Abe K, Tsunoda K, Seino M, Yasujima M, Imai Y, Chiba S, Sato M, Haruyama T, Omata K.
    Tohoku J Exp Med; 1986 Jun 15; 149(2):169-81. PubMed ID: 2944248
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.